Semaglutide News and Research

Latest Semaglutide News and Research

Amycretin delivers unprecedented weight loss in early trial for obesity treatment

Amycretin delivers unprecedented weight loss in early trial for obesity treatment

New oral drug shows promise for type 2 diabetes and obesity without side effects

New oral drug shows promise for type 2 diabetes and obesity without side effects

Diabetes medication shows promise in cutting migraine days by more than half

Diabetes medication shows promise in cutting migraine days by more than half

New ACC guidance helps incorporate pharmacologic weight management strategies into cardiovascular care

New ACC guidance helps incorporate pharmacologic weight management strategies into cardiovascular care

How early-life factors raise lifelong diabetes risks in youth

How early-life factors raise lifelong diabetes risks in youth

Oxytocin stimulates pancreatic hormones to improve insulin secretion

Oxytocin stimulates pancreatic hormones to improve insulin secretion

Bariatric surgery linked to lower risk of psychiatric disorders than GLP-1 drugs

Bariatric surgery linked to lower risk of psychiatric disorders than GLP-1 drugs

Bariatric surgery leads to greater weight loss than GLP-1 drugs after two years

Bariatric surgery leads to greater weight loss than GLP-1 drugs after two years

Could a diabetes drug be the key to stopping Alzheimer’s?

Could a diabetes drug be the key to stopping Alzheimer’s?

Uncovering unexpected impacts of popular GLP-1 diabetes drugs

Uncovering unexpected impacts of popular GLP-1 diabetes drugs

Estrogen-responsive cells found to heighten gut pain in females

Estrogen-responsive cells found to heighten gut pain in females

A revolutionary drug for extreme hunger offers clues to obesity’s complexity

A revolutionary drug for extreme hunger offers clues to obesity’s complexity

New data reveals insights into cancer and cardiovascular safety of JAK inhibitors

New data reveals insights into cancer and cardiovascular safety of JAK inhibitors

AMA endorses resolution to expand access to anti-obesity medications

AMA endorses resolution to expand access to anti-obesity medications

Tufts researchers design new generation of weight loss medications

Tufts researchers design new generation of weight loss medications

Weight loss drug semaglutide proven safe and effective for people with schizophrenia

Weight loss drug semaglutide proven safe and effective for people with schizophrenia

Real-world study finds lower weight loss with GLP-1 drugs due to early discontinuation

Real-world study finds lower weight loss with GLP-1 drugs due to early discontinuation

Bipartisan obesity bill gains support from Endocrine Society

Bipartisan obesity bill gains support from Endocrine Society

Leading health organizations release guidance on nutrition support for GLP-1 obesity therapies

Leading health organizations release guidance on nutrition support for GLP-1 obesity therapies

Genetic factors influence obesity risk in children exposed to gestational diabetes

Genetic factors influence obesity risk in children exposed to gestational diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.